Catalog Product
Resource
Services & Solutions
News
Contact
Career
Jan 20,2023
Lipid Nanoparticle(LNP) Platform
The video demonstrates the molecules our LNP platform can support.
Watch
Dec 20,2022
Case Study: An siRNA Drug Product IND Filing Ready in 10 Months
Small interfering RNA therapeutics are advanced oligonucleotide therapy. WuXi STA oligonucleotide CRDMO platform provides the integrated solution for siRNA candidates.
Sep 28,2022
DNA G-Quadruplexes kilo-Grams Scale Production with Controlled Heavy Metal Strategy
An efficient method was developed to purge the heavy metal and control the residue at low level in final G-Quadruplexes oligonucleotide.
Sep 24,2022
Accelerating PPMO Development and Large-scale Manufacturing with Integrated Peptide
In this talk, we will demonstrate how our unique integrated capability in both peptide and oligonucleotide has enabled our clients to quickly advance important PPMO drugs into clinical studies.
Aug 03,2022
Oligonucleotide Drug Development (CMC)
* Explore synthesis strategies and analytical methodologies * Compare the advantages and disadvantages of different formulation strategies * Review the latest CMC strategies and regulatory framework
Oligonucleotide Drug Discovery
* Examine the synthesis and modification of oligonucleotides* Explore methods for determining pharmacokinetic parameters* Hear about state of the art discovery strategies